People With Type 2 Diabetes Have a Greater Risk of Cardiovascular Disease Even With Risk Factors Optimally Controlled
December 02, 2020 02:30pm
The products were distributed between November 1, 2014 and September 3, 2015.
All non-expired drugs made for sterile usage by the Alabama-based compounder Medistat Rx have been recalled due to concerns of possible contamination which put patients at risk for potentially life-threatening complications. The products were distributed between November 1, 2014 and September 3, 2015. Patients and healthcare professionals should take action. Healthcare providers should check their stock and quarantine the product(s) if in their possession. Patients should contact their doctor if they have received any product from Medistat Rx. All adverse reactions should be reported to FDA’s MedWatch program.
As of September 1, 2015, Medistat Rx has ceased all sterile compounding operations following probes by FDA and the state of Alabama which found discrepancies in their compounding practices. The FDA is involved in continuous efforts with the Alabama Board of Pharmacy to ensure that the health of the public is paramount.
More information is available atPharmacyTimes.com.